Cash & equivalents increased 83.5%
Cash & equivalents changed +83.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +83.5% from the comparable as-filed period.
Gross profit changed +35.6% from the comparable as-filed period.
Net income changed +51.7% from the comparable as-filed period.
Operating income changed -143.2% from the comparable as-filed period.
Research & development changed +33.3% from the comparable as-filed period.
Revenue changed +30.5% from the comparable as-filed period.
Selling, general & administrative changed +45.7% from the comparable as-filed period.
Operating margin changed -140 basis points from the comparable as-filed period.
Gross margin changed +82 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.